This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n12http://linked.opendata.cz/resource/drugbank/drug/DB07629/identifier/chemspider/
n6http://bio2rdf.org/drugbank:
n10http://linked.opendata.cz/resource/drugbank/drug/DB07629/identifier/pdb/
admshttp://www.w3.org/ns/adms#
n11http://linked.opendata.cz/resource/drugbank/drug/DB07629/identifier/pubchem-compound/
n13http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
n9http://linked.opendata.cz/resource/drugbank/drug/DB07629/identifier/pubchem-substance/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n14http://linked.opendata.cz/resource/drugbank/drug/DB07629/identifier/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB07629
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n6:DB07629 n13:DB07629
dcterms:title
N-((1R,2S)-2-(5-CHLORO-1H-INDOLE-2-CARBOXAMIDO)CYCLOHEXYL)-5-METHYL-4,5,6,7-TETRAHYDROTHIAZOLO[5,4-C]PYRIDINE-2-CARBOXAMIDE
adms:identifier
n9:99444100 n10:D92 n11:24752832 n12:23305565 n14:DB07629
n3:IUPAC-Name
n4:271B56F8-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B56FE-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B56FD-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B56FA-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B56FB-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B56FC-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B56F6-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B56F4-363D-11E5-9242-09173F13E4C5 n4:271B56F7-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B56F5-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B5704-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B5705-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B56FF-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B5700-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B5702-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B5701-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B5703-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B570A-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B570C-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B570D-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B5709-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B5708-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B570B-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B56F9-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B5706-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B5707-363D-11E5-9242-09173F13E4C5